Xponance’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,022
| Closed | -$230K | – | 1302 |
|
|
2023
Q1 | $230K | Sell |
3,022
-341
| -10% | -$26K | ﹤0.01% | 1099 |
|
|
2022
Q4 | $279K | Sell |
3,363
-522
| -13% | -$43.3K | ﹤0.01% | 1049 |
|
|
2022
Q3 | $308K | Sell |
3,885
-2,205
| -36% | -$175K | 0.01% | 989 |
|
|
2022
Q2 | $452K | Hold |
6,090
| – | – | 0.01% | 894 |
|
|
2022
Q1 | $547K | Hold |
6,090
| – | – | 0.01% | 866 |
|
|
2021
Q4 | $682K | Hold |
6,090
| – | – | 0.01% | 777 |
|
|
2021
Q3 | $766K | Hold |
6,090
| – | – | 0.01% | 683 |
|
|
2021
Q2 | $825K | Hold |
6,090
| – | – | 0.02% | 677 |
|
|
2021
Q1 | $826K | Sell |
6,090
-1,333
| -18% | -$181K | 0.02% | 552 |
|
|
2020
Q4 | $1.05M | Hold |
7,423
| – | – | 0.02% | 450 |
|
|
2020
Q3 | $827K | Buy |
+7,423
| New | +$827K | 0.02% | 474 |
|